Stolz Brian M.
Insider CIK 1524803 · BBIO Chief Operating Officer · ATVI Chief People Officer · VRX EVP, CHCO and Administration
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-08-16 | 2020-08-18 | 1,595 | — | $0 | 23,937 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2020-08-16 | 2020-08-18 | 552 | $28.53 | $15.7K | 24,615 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-08-16 | 2020-08-18 | 1,595 | — | $0 | 25,167 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 183,727 | — | $0 | 183,727 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 25,532 | — | $0 | 25,532 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-12-12 | 2019-12-16 | 72,696 | — | $0 | 72,696 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-11-13 | 2019-11-15 | 106,469 | — | $0 | 106,469 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-11-13 | 2019-11-15 | 102,081 | — | $0 | 102,081 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2019-11-13 | 2019-11-15 | 22,839 | — | $0 | 22,839 | SEC↗ |
| ATVI Activision Blizzard, Inc. | M Exercise deriv | 2019-08-13 | 2019-08-15 | 134,845 | — | $0 | 44,948 | SEC↗ |
| ATVI Activision Blizzard, Inc. | S Sale | 2019-08-13 | 2019-08-15 | 134,845 | $47.80 | $6.45M | 108,041 | SEC↗ |
| ATVI Activision Blizzard, Inc. | M Exercise | 2019-08-13 | 2019-08-15 | 134,845 | $40.61 | $5.48M | 242,886 | SEC↗ |
| ATVI Activision Blizzard, Inc. | F Tax w/h | 2019-05-30 | 2019-06-03 | 36,405 | $43.56 | $1.59M | 108,041 | SEC↗ |
| ATVI Activision Blizzard, Inc. | A Award | 2018-11-12 | 2018-11-14 | 11,598 | — | $0 | 157,120 | SEC↗ |
| ATVI Activision Blizzard, Inc. | A Award | 2017-11-06 | 2017-11-08 | 10,268 | — | $0 | 145,522 | SEC↗ |
| ATVI Activision Blizzard, Inc. | A Award | 2016-11-07 | 2016-11-09 | 15,210 | — | $0 | 135,254 | SEC↗ |
| ATVI Activision Blizzard, Inc. | A Award deriv | 2016-08-08 | 2016-08-10 | 179,793 | — | $0 | 179,793 | SEC↗ |
| ATVI Activision Blizzard, Inc. | A Award | 2016-08-08 | 2016-08-10 | 120,044 | — | $0 | 120,044 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-06-22 | 2015-06-24 | 2,292 | — | $0 | 125,280 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-05-01 | 2015-05-05 | 3,675 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-05-01 | 2015-05-05 | 1,921 | — | $0 | 94,139 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-05-01 | 2015-05-05 | 3,675 | — | $0 | 96,060 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-01-26 | 2015-01-28 | 760 | — | $0 | 92,385 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-01-22 | 2015-01-26 | 7,350 | — | $0 | 3,675 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-01-22 | 2015-01-26 | 7,350 | — | $0 | 95,934 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-01-22 | 2015-01-26 | 2,789 | — | $0 | 93,145 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-12-23 | 2014-12-24 | 15,426 | — | $0 | 33,433 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-12-23 | 2014-12-24 | 15,426 | — | $0 | 96,618 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-12-23 | 2014-12-24 | 8,034 | — | $0 | 88,584 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-10-28 | 2014-10-30 | 908 | — | $0 | 81,192 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-10-23 | 2014-10-27 | 784 | — | $0 | 82,100 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-10-10 | 2014-10-14 | 3,675 | — | $0 | 11,025 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-10-10 | 2014-10-14 | 1,907 | — | $0 | 82,884 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-10-10 | 2014-10-14 | 3,675 | — | $0 | 84,791 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-09-30 | 2014-10-02 | 23,030 | — | $0 | 45,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-09-30 | 2014-10-02 | 11,948 | — | $0 | 81,116 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-09-30 | 2014-10-02 | 23,030 | — | $0 | 93,064 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-08-06 | 2014-08-07 | 18,111 | — | $0 | 45,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-08-06 | 2014-08-07 | 9,397 | — | $0 | 70,034 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-08-06 | 2014-08-07 | 18,111 | — | $0 | 79,431 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-07-23 | 2014-07-23 | 867 | — | $0 | 61,320 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-02-11 | 2014-02-12 | 14,700 | — | $0 | 14,700 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-02-11 | 2014-02-12 | 7,596 | — | $0 | 62,187 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-02-11 | 2014-02-12 | 14,700 | — | $0 | 69,783 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-01-20 | 2014-01-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-20 | 2014-01-22 | 22,281 | — | $0 | 55,658 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-20 | 2014-01-22 | 332 | — | $0 | 55,326 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-20 | 2014-01-22 | 243 | — | $0 | 55,083 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-01-20 | 2014-01-22 | 45,000 | — | $0 | 77,939 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-10-24 | 2013-10-28 | 892 | — | $0 | 42,939 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-10-20 | 2013-10-22 | 4,500 | — | $0 | 43,831 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-08-21 | 2013-08-21 | 14,700 | — | $0 | 14,700 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-08-21 | 2013-08-21 | 14,700 | — | $0 | 46,856 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-08-21 | 2013-08-21 | 7,525 | — | $0 | 39,331 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-08-12 | 2013-08-12 | 4,500 | $100.71 | $453.2K | 32,156 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-20 | 2013-07-23 | 687 | — | $0 | 27,656 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-01-20 | 2013-01-22 | 347 | — | $0 | 28,343 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-11-07 | 2012-11-08 | 2,040 | $52.76 | $107.6K | 26,650 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-24 | 2012-10-26 | 650 | — | $0 | 24,610 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-07-20 | 2012-07-24 | 5,000 | — | $0 | 25,260 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-05-10 | 2012-05-14 | 5,000 | $53.10 | $265.5K | 20,260 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-01-20 | 2013-01-22 | 2,040 | — | $0 | 28,690 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-01-20 | 2012-01-24 | 2,400 | — | $0 | 15,260 | SEC↗ |